Shanghai No. 1 Pharmacy Co. Ltd. said its normalized net income for the first quarter was 4 fen per share, an increase of 12.6% from 4 fen per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 9.4 million yuan, an increase of 12.7% from 8.4 million yuan in the year-earlier period.
The normalized profit margin rose to 2.2% from 2.1% in the year-earlier period.
Total revenue rose 8.3% year over year to 423.2 million yuan from 390.7 million yuan, and total operating expenses rose 8.5% year over year to 409.7 million yuan from 377.6 million yuan.
Reported net income rose 16.7% on an annual basis to 12.0 million yuan, or 5 fen per share, from 10.3 million yuan, or 5 fen per share.
As of April 29, US$1 was equivalent to 6.20 yuan.
